{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:18:54Z","timestamp":1793963934646,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13046-016-0395-y","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T01:34:36Z","timestamp":1469064876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Nerve growth factor: role in growth, differentiation and controlling cancer cell development"],"prefix":"10.1186","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-1283","authenticated-orcid":false,"given":"Luigi","family":"Aloe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijorn Omar","family":"Balzamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Micera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"key":"395_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jez.1401160206","volume":"116","author":"R Levi-Montalcini","year":"1951","unstructured":"Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951;116:321\u201361.","journal-title":"J Exp Zool"},{"key":"395_CR2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","volume":"237","author":"R Levi-Montalcini","year":"1987","unstructured":"Levi-Montalcini R. The nerve growth factor 35\u00a0years later. Science. 1987;237:1154\u201362.","journal-title":"Science"},{"key":"395_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0166-2236(92)90047-C","volume":"15","author":"SO Meakin","year":"1992","unstructured":"Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci. 1992;15:323\u201331.","journal-title":"Trends Neurosci"},{"key":"395_CR4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217\u201312.","journal-title":"Annu Rev Neurosci"},{"key":"395_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/329065a0","volume":"329","author":"W Fischer","year":"1987","unstructured":"Fischer W, Wictorin K, Bjorklund A, et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987;329:65\u20138.","journal-title":"Nature"},{"key":"395_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00004-6","volume":"27","author":"B Connor","year":"1998","unstructured":"Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of human brain. Brain Res Rev. 1998;27:1\u201339.","journal-title":"Brain Res Rev"},{"key":"395_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","volume":"50","author":"SC Apfel","year":"2002","unstructured":"Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol. 2002;50:393\u2013413.","journal-title":"Int Rev Neurobiol"},{"key":"395_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(94)90252-6","volume":"634","author":"SC Apfel","year":"1994","unstructured":"Apfel SC, Arezzo JC, Brownlee M, et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 1994;634:7\u201312.","journal-title":"Brain Res"},{"key":"395_CR9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.51.3.695","volume":"51","author":"SC Apfel","year":"1998","unstructured":"Apfel SC, Kessler JA, Adornato BT, et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF study group. Neurology. 1998;51:695\u2013702.","journal-title":"Neurology"},{"key":"395_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40259-013-0079-5","volume":"28","author":"MP Ferrari","year":"2014","unstructured":"Ferrari MP, Mantelli F, Sacchetti M, et al. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial. BioDrugs. 2014;28:275\u201383.","journal-title":"BioDrugs"},{"key":"395_CR11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","volume":"338","author":"A Lambiase","year":"1998","unstructured":"Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998;338:1174\u201380.","journal-title":"N Engl J Med"},{"key":"395_CR12","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","volume":"106","author":"A Lambiase","year":"2009","unstructured":"Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci U S A. 2009;106:13469\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR13","first-page":"439","volume":"45","author":"A Lambiase","year":"2009","unstructured":"Lambiase A, Coassin M, Tirassa P, et al. Nerve growth factor eye drops improve visual acuity and electro functional activity in age-related macular degeneration: a case report. Ann Ist Super Sanita. 2009;45:439\u201342.","journal-title":"Ann Ist Super Sanita"},{"key":"395_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124810","volume":"10","author":"ML Rocco","year":"2015","unstructured":"Rocco ML, Balzamino BO, Petrocchi Passeri P, et al. Effect of purified murine NGF on isolated photoreceptors of a rodent developing retinitis pigmentosa. PLoS One. 2015;10, e0124810.","journal-title":"PLoS One"},{"key":"395_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410300502","volume":"30","author":"MH Tuszynski","year":"1991","unstructured":"Tuszynski MH, Sang H, Yoshida K, Gage FH. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol. 1991;30:625\u201336.","journal-title":"Ann Neurol"},{"key":"395_CR16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-141068","volume":"43","author":"D Ferreira","year":"2015","unstructured":"Ferreira D, Westman E, Eyjolfsdottir H, et al. Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor. J Alzheimers Dis. 2015;43:1059\u201372.","journal-title":"J Alzheimers Dis"},{"key":"395_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1073\/pnas.74.2.565","volume":"74","author":"RN Fabricant","year":"1977","unstructured":"Fabricant RN, De Larco JE, Todaro GJ. Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci U S A. 1977;74:565\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1073\/pnas.76.3.1246","volume":"76","author":"L Aloe","year":"1979","unstructured":"Aloe L, Levi-Montalcini R. Nerve growth factor-induced transformation of immature chromaffin cells in vivo into sympathetic neurons: effect of antiserum to nerve growth factor. Proc Natl Acad Sci U S A. 1979;76:1246\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3940(85)90232-0","volume":"60","author":"K Unsicker","year":"1985","unstructured":"Unsicker K, Skaper SD, Varon S. Phenotypical changes of embryonic chick adrenal medullary cells in vitro induced by nerve growth factor and ciliary neuronotrophic factor. Neurosci Lett. 1985;60:127\u201332.","journal-title":"Neurosci Lett"},{"key":"395_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(03)46011-1","volume":"146","author":"F Angelucci","year":"2004","unstructured":"Angelucci F, Math\u00e9 AA, Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res. 2004;146:151\u201365.","journal-title":"Prog Brain Res"},{"key":"395_CR21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","volume":"19","author":"R Levi-Montalcini","year":"1996","unstructured":"Levi-Montalcini R, Skaper SD, Dal Toso R, et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 1996;19:514\u201320.","journal-title":"Trends Neurosci"},{"key":"395_CR22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1152\/physrev.1968.48.3.534","volume":"48","author":"R Levi-Montalcini","year":"1968","unstructured":"Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev. 1968;48:534\u201369.","journal-title":"Physiol Rev"},{"key":"395_CR23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bjc.2015.274","volume":"113","author":"L Dubanet","year":"2015","unstructured":"Dubanet L, Bentayeb H, Petit B, et al. Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas. Br J Cancer. 2015;113:934\u201344.","journal-title":"Br J Cancer"},{"key":"395_CR24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF00299412","volume":"83","author":"MJ Yaeger","year":"1992","unstructured":"Yaeger MJ, Koestner A, Marushige K, Marushige Y. The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results. Acta Neuropathol. 1992;83:624\u20139.","journal-title":"Acta Neuropathol"},{"key":"395_CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1227\/00006123-199302000-00017","volume":"32","author":"GE Keles","year":"1993","unstructured":"Keles GE, Berger MS, Schofield D, Bothwell M. Nerve growth factor receptor expression in medulloblastomas and the potential role of the nerve growth factor as a differentiating agent in medulloblastomas cell lines. Neurosurgery. 1993;32:274\u201380.","journal-title":"Neurosurgery"},{"key":"395_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02706217","volume":"28","author":"S Wadhwa","year":"2003","unstructured":"Wadhwa S, Nag TC, Jindal A, et al. Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma. J Biosci. 2003;28:181\u20138.","journal-title":"J Biosci"},{"key":"395_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01324703","volume":"16","author":"W Hamel","year":"1993","unstructured":"Hamel W, Westphal M, Shepard HM. Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. J Neurooncol. 1993;16:159\u201365.","journal-title":"J Neurooncol"},{"key":"395_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0304-3835(80)90047-6","volume":"10","author":"SA Vinores","year":"1980","unstructured":"Vinores SA, Koestner A. The effect of nerve growth factor on undifferentiated glioma cells. Cancer Lett. 1980;10:309\u201318.","journal-title":"Cancer Lett"},{"key":"395_CR29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/BF01946760","volume":"29","author":"T Waris","year":"1973","unstructured":"Waris T, Rechardt L, Waris P. Differentiation of neuroblastoma cells induced by nerve growth factor in vitro. Experientia. 1973;29:1128\u20139.","journal-title":"Experientia"},{"key":"395_CR30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199303253281205","volume":"328","author":"A Nakagawara","year":"1993","unstructured":"Nakagawara A, Nakagawara AM, Scavarda NJ, et al. Association between high levels of expression of the trk gene and favourable outcome. N Engl J Med. 1993;328:847\u201354.","journal-title":"N Engl J Med"},{"key":"395_CR31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/07357900701205689","volume":"25","author":"A Antonelli","year":"2007","unstructured":"Antonelli A, Lenzi L, Nakagawara A, et al. Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor. Cancer Invest. 2007;25:94\u2013101.","journal-title":"Cancer Invest"},{"key":"395_CR32","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1073\/pnas.83.16.6184","volume":"83","author":"L Aloe","year":"1986","unstructured":"Aloe L, Alleva E, B\u00f6hm A, Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci U S A. 1986;83:6184\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR33","first-page":"341","volume":"50","author":"E Alleva","year":"1990","unstructured":"Alleva E, Calamandrei G. On the functional role of polypeptide growth factors in rodent neurobehavioral development. Acta Neurobiol Exp. 1990;50:341\u201352.","journal-title":"Acta Neurobiol Exp"},{"key":"395_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/08977190903578678","volume":"28","author":"N Arrighi","year":"2010","unstructured":"Arrighi N, Bodei S, Zani D, et al. Nerve growth factor signaling in prostate health and disease. Growth Factors. 2010;28:191\u2013201.","journal-title":"Growth Factors"},{"key":"395_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1254\/jphs.09354SC","volume":"112","author":"M Goda","year":"2010","unstructured":"Goda M, Atagi S, Amitani K, et al. Nerve growth factor suppresses prostate tumor growth. J Pharmacol Sci. 2010;112:463\u20136.","journal-title":"J Pharmacol Sci"},{"key":"395_CR36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13046-015-0222-x","volume":"34","author":"A Singh","year":"2015","unstructured":"Singh A, Ruan Y, Tippett T, et al. Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells. J Exp Clin Cancer Res. 2015;34:104.","journal-title":"J Exp Clin Cancer Res"},{"key":"395_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13046-015-0234-6","volume":"34","author":"B Guerra","year":"2015","unstructured":"Guerra B, Fischer M, Schaefer S, et al. The kinase inhibitor D11 induces caspase-mediated cell death in cancer cells resistant to chemotherapeutic treatment. J Exp Clin Cancer Res. 2015;34:125.","journal-title":"J Exp Clin Cancer Res"},{"key":"395_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-015-0163-4","volume":"34","author":"B Wu","year":"2015","unstructured":"Wu B, Sun C, Feng F, et al. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis. J Exp Clin Cancer Res. 2015;34:44.","journal-title":"J Exp Clin Cancer Res"},{"key":"395_CR39","first-page":"105","volume":"7","author":"ZW Zhu","year":"2001","unstructured":"Zhu ZW, Friess H, Wang L, et al. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res. 2001;7:105\u201312.","journal-title":"Clin Cancer Res"},{"key":"395_CR40","first-page":"161","volume":"14","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Dang C, Ma Q, Shimahara Y. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Oncol Rep. 2005;14:161\u201371.","journal-title":"Oncol Rep"},{"key":"395_CR41","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1073\/pnas.90.17.7961","volume":"90","author":"C Missale","year":"1993","unstructured":"Missale C, Boroni F, Losa M, et al. Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci U S A. 1993;90:7961\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR42","first-page":"740187","volume":"2013","author":"AR Farina","year":"2013","unstructured":"Farina AR, Di Ianni N, Cappabianca L, et al. TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. Biomed Res Int. 2013;2013:740187.","journal-title":"Biomed Res Int"},{"issue":"3","key":"395_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.49","volume":"7","author":"P Ruggeri","year":"2016","unstructured":"Ruggeri P, Cappabianca L, Farina AR, et al. NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells. Cell Death Dis. 2016;7(3), e2139.","journal-title":"Cell Death Dis"},{"key":"395_CR44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.humpath.2006.06.027","volume":"38","author":"E \u00d8degaard","year":"2007","unstructured":"\u00d8degaard E, Staff AC, Abeler VM, et al. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. Hum Pathol. 2007;38:140\u20136.","journal-title":"Hum Pathol"},{"key":"395_CR45","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","volume":"73","author":"LA Greene","year":"1976","unstructured":"Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 1976;73:2424\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/1545968310395601","volume":"25","author":"A Chiaretti","year":"2011","unstructured":"Chiaretti A, Falsini B, Servidei S, et al. Nerve growth factor eye drop administration improves visual function in a patient with optic glioma. Neurorehabil Neural Repair. 2011;25:386\u201390.","journal-title":"Neurorehabil Neural Repair"},{"key":"395_CR47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","volume":"411","author":"SA Rosenberg","year":"2001","unstructured":"Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380\u20134.","journal-title":"Nature"},{"key":"395_CR48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277\u201388.","journal-title":"Nat Rev Cancer"},{"key":"395_CR49","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14:1014\u201322.","journal-title":"Nat Immunol"},{"key":"395_CR50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159\u201370.","journal-title":"Cell"},{"key":"395_CR51","doi-asserted-by":"crossref","first-page":"28010","DOI":"10.1074\/jbc.M109730200","volume":"277","author":"V Mamidipudi","year":"2002","unstructured":"Mamidipudi V, Li X, Wooten MW. Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B. J Biol Chem. 2002;277:28010\u20138.","journal-title":"J Biol Chem"},{"key":"395_CR52","first-page":"2656","volume":"32","author":"JA Swenberg","year":"1972","unstructured":"Swenberg JA, Koestner A, Wechsler W, Denlinger RH. Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats. Cancer Res. 1972;32:2656\u201360.","journal-title":"Cancer Res"},{"key":"395_CR53","first-page":"7120","volume":"49","author":"NR Raju","year":"1989","unstructured":"Raju NR, Koestner A, Marushige K, et al. Effect of nerve growth factor on the transplacental induction of neurinomas by ethylnitrosourea in Sprague\u2013Dawley rats. Cancer Res. 1989;49:7120\u20133.","journal-title":"Cancer Res"},{"key":"395_CR54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1545968310397201","volume":"25","author":"B Falsini","year":"2011","unstructured":"Falsini B, Chiaretti A, Barone G, et al. Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology. Neurorehabil Neural Repair. 2011;25:512\u201320.","journal-title":"Neurorehabil Neural Repair"},{"key":"395_CR55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1019919019497","volume":"59","author":"C Kanaka-Gantenbein","year":"2002","unstructured":"Kanaka-Gantenbein C, Dicou E, Czernichow P, Scharfmann R. Growth control of C6 glioma in vivo by nerve growth factor. J Neurooncol. 2002;59:199\u2013205.","journal-title":"J Neurooncol"},{"key":"395_CR56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cytogfr.2007.04.004","volume":"18","author":"A Micera","year":"2007","unstructured":"Micera A, Lambiase A, Stampachiacchiere B, et al. Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev. 2007;18:245\u201356.","journal-title":"Cytokine Growth Factor Rev"},{"key":"395_CR57","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650\u20139.","journal-title":"N Engl J Med"},{"key":"395_CR58","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0006-3495(02)75222-3","volume":"83","author":"PS Mischel","year":"2002","unstructured":"Mischel PS, Umbach JA, Eskandari S, et al. Nerve growth factor signals via preexisting TrkA receptor oligomers. Biophys J. 2002;83:968\u201376.","journal-title":"Biophys J"},{"key":"395_CR59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324\u201331.","journal-title":"Nature"},{"key":"395_CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916939409009542","volume":"19","author":"L Aloe","year":"1994","unstructured":"Aloe L, Skaper SD, Leon A, Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity. 1994;19:141\u201350.","journal-title":"Autoimmunity"},{"key":"395_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(88)90129-4","volume":"18","author":"L Aloe","year":"1988","unstructured":"Aloe L. The effect of nerve growth factor and its antibody on mast cells in vivo. J Neuroimmunol. 1988;18:1\u201312.","journal-title":"J Neuroimmunol"},{"key":"395_CR62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-5728(01)00475-1","volume":"123","author":"L Bracci-Laudiero","year":"2002","unstructured":"Bracci-Laudiero L, Aloe L, Buanne P, et al. NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF? J Neuroimmunol. 2002;123:58\u201365.","journal-title":"J Neuroimmunol"},{"key":"395_CR63","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1073\/pnas.86.24.10059","volume":"86","author":"U Otten","year":"1989","unstructured":"Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A. 1989;86:10059\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"395_CR64","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.148.11.3492","volume":"148","author":"C Brodie","year":"1992","unstructured":"Brodie C, Gelfand EW. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol. 1992;148:3492\u20137.","journal-title":"J Immunol"},{"key":"395_CR65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)81113-7","volume":"85","author":"M Torcia","year":"1996","unstructured":"Torcia M, Bracci-Laudiero L, Lucibello M, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 1996;85:345\u201356.","journal-title":"Cell"},{"key":"395_CR66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0091-6749(98)70135-6","volume":"102","author":"A Solomon","year":"1998","unstructured":"Solomon A, Aloe L, Pe'er J, et al. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol. 1998;102:454\u201360.","journal-title":"J Allergy Clin Immunol"},{"key":"395_CR67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0091-6749(97)70256-2","volume":"100","author":"A Lambiase","year":"1997","unstructured":"Lambiase A, Bracci-Laudiero L, Bonini S, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. Allergy Clin Immunol. 1997;100:408\u201314.","journal-title":"Allergy Clin Immunol"},{"key":"395_CR68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00130832-200410000-00015","volume":"4","author":"A Lambiase","year":"2004","unstructured":"Lambiase A, Micera A, Sgrulletta R, et al. Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions. Curr Opin Allergy Clin Immunol. 2004;4:425\u201330.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"395_CR69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-4598-9-157","volume":"9","author":"R Romon","year":"2010","unstructured":"Romon R, Adriaenssens E, Lagadec C, et al. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer. 2010;9:157.","journal-title":"Mol Cancer"},{"key":"395_CR70","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/bjc.2011.164","volume":"104","author":"TJ Molloy","year":"2011","unstructured":"Molloy TJ, Devriese LA, Helgason HH, et al. A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer. Br J Cancer. 2011;104:1913\u20139.","journal-title":"Br J Cancer"},{"key":"395_CR71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1152\/physiol.00045.2009","volume":"25","author":"E Witsch","year":"2010","unstructured":"Witsch E, Sela M, Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda). 2010;25:85\u2013101.","journal-title":"Physiology (Bethesda)"},{"key":"395_CR72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nm0198-013","volume":"4","author":"D Hanahan","year":"1998","unstructured":"Hanahan D. A flanking attack on cancer. Nat Med. 1998;4:13\u20134.","journal-title":"Nat Med"},{"key":"395_CR73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(02)00757-8","volume":"73","author":"L Aloe","year":"2002","unstructured":"Aloe L, Alleva E, Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacol Biochem Behav. 2002;73:159\u201366.","journal-title":"Pharmacol Biochem Behav"},{"key":"395_CR74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(92)90684-Y","volume":"140","author":"D Maysinger","year":"1992","unstructured":"Maysinger D, Jalsenjak I, Cuello AC. Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions. Neurosci Lett. 1992;140:71\u20134.","journal-title":"Neurosci Lett"},{"key":"395_CR75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","volume":"1","author":"XQ Chen","year":"1998","unstructured":"Chen XQ, Fawcett JR, Rahman YE, et al. Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway. J Alzheimers Dis. 1998;1:35\u201344.","journal-title":"J Alzheimers Dis"},{"key":"395_CR76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(99)02784-1","volume":"354","author":"R Bernabei","year":"1999","unstructured":"Bernabei R, Landi F, Bonini S, et al. Effect of topical application of nerve-growth factor on pressure ulcers. Lancet. 1999;354:307.","journal-title":"Lancet"},{"key":"395_CR77","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(00)03212-8","volume":"356","author":"M Tuveri","year":"2000","unstructured":"Tuveri M, Generini S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet. 2000;356:1739\u201340.","journal-title":"Lancet"},{"key":"395_CR78","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1055\/s-2004-821313","volume":"112","author":"S Generini","year":"2004","unstructured":"Generini S, Tuveri MA, Matucci Cerinic M, et al. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp Clin Endocrinol Diabetes. 2004;112:542\u20134.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"395_CR79","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-139-8-200310210-00006","volume":"139","author":"F Landi","year":"2003","unstructured":"Landi F, Aloe L, Russo A, et al. Topical treatment of pressure ulcers with nerve growth factor: a randomized clinical trial. Ann Intern Med. 2003;139:635\u201341.","journal-title":"Ann Intern Med"},{"key":"395_CR80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-3806(82)90094-3","volume":"256","author":"L Aloe","year":"1982","unstructured":"Aloe L, Calissano P, Levi-Montalcini R. Effects of oral administration of nerve growth factor and of its antiserum on sympathetic ganglia of neonatal mice. Brain Res. 1982;256:31\u20134.","journal-title":"Brain Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-016-0395-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T10:17:02Z","timestamp":1718705822000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-016-0395-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1186\/s13046-016-0395-y","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]},"article-number":"116"}}